Jim Cramer Says 'Take A Pass' On This Tech Stock, Won't Go Near Oils

Summary of Key Points Group 1: Company Recommendations - Zoom Communications Inc. is considered a good company but lacks a catalyst for investment recommendation, leading to advice to "take a pass" [1] - Viking Therapeutics, Inc. reported quarterly losses of 81 cents per share, missing the analyst consensus estimate of a loss of 72 cents per share [2] - Eli Lilly and Company is recommended over Viking Therapeutics [2] Group 2: Earnings Reports - Altria Group, Inc. reported third-quarter adjusted earnings per share of $1.45, which is a 3.6% year-over-year increase and in line with analyst consensus [2] - Altria's quarterly sales were $6.072 billion, down 3% year-over-year, but exceeded the Street view of $5.309 billion [2] Group 3: Analyst Ratings and Price Targets - Piper Sandler analyst maintained ProFrac Holding Corp. with a Neutral rating and lowered the price target from $6 to $5 [1] - Jim Cramer expressed a negative outlook on oil stocks, stating they are "all going lower" and advised against investing in them [1] Group 4: Stock Price Movements - Viking Therapeutics shares fell 3.8% to settle at $34.63 [4] - Altria shares rose 1.1% to close at $57.31 [4] - Zoom shares fell 2.8% to settle at $83.83 [4] - ProFrac shares dipped 7.6% to close at $5.12 [4]